Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells.
![Thumbnail](/bitstream/handle/internal/3901/Shieldin%20complex%20promotes%20DNA%20end-joining%20and%20counters%20homologous%20recombination%20in%20BRCA1-null%20cells.pdf.jpg?sequence=18&isAllowed=y)
View/ Open
Date
2018-08-01ICR Author
Author
Dev, H
Chiang, T-WW
Lescale, C
de Krijger, I
Martin, AG
Pilger, D
Coates, J
Sczaniecka-Clift, M
Wei, W
Ostermaier, M
Herzog, M
Lam, J
Shea, A
Demir, M
Wu, Q
Yang, F
Fu, B
Lai, Z
Balmus, G
Belotserkovskaya, R
Serra, V
O'Connor, MJ
Bruna, A
Beli, P
Pellegrini, L
Caldas, C
Deriano, L
Jacobs, JJL
Galanty, Y
Jackson, SP
Type
Journal Article
Metadata
Show full item recordAbstract
BRCA1 deficiencies cause breast, ovarian, prostate and other cancers, and render tumours hypersensitive to poly(ADP-ribose) polymerase (PARP) inhibitors. To understand the resistance mechanisms, we conducted whole-genome CRISPR-Cas9 synthetic-viability/resistance screens in BRCA1-deficient breast cancer cells treated with PARP inhibitors. We identified two previously uncharacterized proteins, C20orf196 and FAM35A, whose inactivation confers strong PARP-inhibitor resistance. Mechanistically, we show that C20orf196 and FAM35A form a complex, 'Shieldin' (SHLD1/2), with FAM35A interacting with single-stranded DNA through its C-terminal oligonucleotide/oligosaccharide-binding fold region. We establish that Shieldin acts as the downstream effector of 53BP1/RIF1/MAD2L2 to promote DNA double-strand break (DSB) end-joining by restricting DSB resection and to counteract homologous recombination by antagonizing BRCA2/RAD51 loading in BRCA1-deficient cells. Notably, Shieldin inactivation further sensitizes BRCA1-deficient cells to cisplatin, suggesting how defining the SHLD1/2 status of BRCA1-deficient tumours might aid patient stratification and yield new treatment opportunities. Highlighting this potential, we document reduced SHLD1/2 expression in human breast cancers displaying intrinsic or acquired PARP-inhibitor resistance.
Collections
Subject
Cell Line, Tumor
Animals
Humans
Mice
Osteosarcoma
Bone Neoplasms
Breast Neoplasms
Ovarian Neoplasms
Cisplatin
Multiprotein Complexes
Proteins
Cell Cycle Proteins
DNA-Binding Proteins
Telomere-Binding Proteins
BRCA1 Protein
Xenograft Model Antitumor Assays
Dose-Response Relationship, Drug
Drug Resistance, Neoplasm
Female
DNA Breaks, Double-Stranded
HEK293 Cells
DNA End-Joining Repair
Recombinational DNA Repair
Mad2 Proteins
Poly(ADP-ribose) Polymerase Inhibitors
Tumor Suppressor p53-Binding Protein 1
Research team
Preclinical Modelling of Paediatric Cancer Evolution
Language
eng
Date accepted
2018-06-11
License start date
2018-08
Citation
Nature cell biology, 2018, 20 (8), pp. 954 - 965
Publisher
NATURE PUBLISHING GROUP
Related items
Showing items related by title, author, creator and subject.
-
Phosphorylation-mediated interactions with TOPBP1 couple 53BP1 and 9-1-1 to control the G1 DNA damage checkpoint.
Bigot, N; Day, M; Baldock, RA; Watts, FZ; Oliver, AW; et al. (ELIFE SCIENCES PUBLICATIONS LTD, 2019-05-28)Coordination of the cellular response to DNA damage is organised by multi-domain 'scaffold' proteins, including 53BP1 and TOPBP1, which recognise post-translational modifications such as phosphorylation, methylation and ... -
Structural Basis for Auto-Inhibition of the NDR1 Kinase Domain by an Atypically Long Activation Segment.
Xiong, S; Lorenzen, K; Couzens, AL; Templeton, CM; Rajendran, D; et al. (CELL PRESS, 2018-08-07)The human NDR family kinases control diverse aspects of cell growth, and are regulated through phosphorylation and association with scaffolds such as MOB1. Here, we report the crystal structure of the human NDR1 kinase ... -
Multiparametric Analysis of Cell Shape Demonstrates that β-PIX Directly Couples YAP Activation to Extracellular Matrix Adhesion.
Sero, JE; Bakal, C (CELL PRESS, 2017-01-25)Mechanical signals from the extracellular matrix (ECM) and cellular geometry regulate the nuclear translocation of transcriptional regulators such as Yes-associated protein (YAP). Elucidating how physical signals control ...